2023 - Research.com Genetics in United Kingdom Leader Award
2001 - Fellow of the Royal Society, United Kingdom
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
D Ford;D F Easton;M Stratton;S Narod.
American Journal of Human Genetics (1998)
Genome-wide association study identifies novel breast cancer susceptibility loci
Douglas F. Easton;Karen A. Pooley;Alison M. Dunning;Paul D. P. Pharoah.
Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13
Richard Wooster;Susan L. Neuhausen;Jonathan Mangion;Yvette Quirk.
CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
Maria Luisa Brandi;Robert F. Gagel;Alberto Angeli;John P. Bilezikian.
The Journal of Clinical Endocrinology and Metabolism (2001)
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
L M Mulligan;J B Kwok;C S Healey;M J Elsdon.
Degenerate oligonucleotide-primed PCR: General amplification of target DNA by a single degenerate primer
H. Telenius;N. P. Carter;C. E. Bebb;M. Nordenskjold.
The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis.
Charis Eng;Charis Eng;David Clayton;Isabelle Schuffenecker;Gilbert Lenoir.
Catalytic specificity of protein-tyrosine kinases is critical for selective signalling
Zhou Songyang;Zhou Songyang;Kermit L. Carraway;Michael J. Eck;Stephen C. Harrison.
GDNF signalling through the Ret receptor tyrosine kinase
Pascale Durbec;Camelia V. Marcos-Gutierrez;Carol Kilkenny;Maria Grigoriou.
Mutations of the RET proto-oncogene in Hirschsprung's disease
Patrick Edery;Stanislas Lyonnet;Lois M. Mulligan;Anna Pelet.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: